We're buying more of this life sciences stock after an earnings-driven decline
The stock is under pressure in early trading due to uncertainty around the recovery in a key business.

Troov Jun 4, 2025 0 379
Tekef Jun 4, 2025 0 378
KickT Jun 4, 2025 0 335
Hollif May 22, 2025 0 332
AbJimroe May 22, 2025 0 297
Kass Jul 29, 2025 0 7
Hollif Jul 29, 2025 0 6
Kass Jul 29, 2025 0 7
Tfoso Jul 29, 2025 0 6
ValVades Jul 17, 2025 0 166
Canadian giant Alimentation Couche-Tard, which owns Circle K, has dropped its $46bn...
Tfoso Jul 25, 2025 0 158
We can raise BDNF levels in our brain by fasting and exercising, as well as by eating...
MikeTyes Jul 23, 2025 0 151
Despite some valuation gaps, fundamentals in key sectors such as technology and...
FrankLin Jul 29, 2025 0 5
But Publicis responds: 'There was absolutely nothing unusual about preliminary conversation...
AbJimroe Jul 29, 2025 0 6
Ray Dalio, the billionaire behind Bridgewater Associates, says people should think...
Konoly Jul 29, 2025 0 6
Are you looking for ways to leverage AI that go beyond basic text generation? Wondering...
UsenB Jul 29, 2025 0 6
Except for its name, nothing is little about Little Pepe ($LILPEPE). Not its ambition,...
Astrong Jul 29, 2025 0 12
It was a difficult month in July 2025 when multiple stars died, with some passing...
Hollif Jul 29, 2025 0 7
On a 24-hour whirlwind journey, Queenie Shaikh discovers how communities have shaped...
Koichiko Jun 30, 2025 0 575
James Harden is declining his $36.3 million player option and intends to sign a...